Did you know?
ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.
Free Newsletter
Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!
Free Report
For better result, minimum character length is four(4)
Our Executive Editor, Greg Scott, answers questions...
Reports surfaced last week that the SFDA will become part...
WuXi PharmaTech reported that its Q4 revenues were up 64%...
Earnings reports had an effect on China biotech last...
China biopharma stocks listed on US exchanges weathered a...
WuXi PharmaTech announced after the close of trading on...
China biopharma news came from a broad front last week,...
WuXi PharmaTech, the Shanghai-based CRO, formally endowed...
Consolidation was a major theme last week in...
WuXi PharmaTech, the Shanghai-located CRO, has postponed...
ChinaBio® News
Greg Scott Interviewed at BIO-Europe Spring
How to bring your China assets to China in 8 minutes
"Mr. Bio in China."
Mendelspod Interview
Multinational pharma held to a higher standard in China
